Form 4/A for AIM AIM ImmunoTech Inc.
Accepted 2021-12-13 00:00:00 ET · period of report 2021-12-13 · accession 0001450324-21-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2021-12-13 | 2021-12-13 | AIM | Equels Thomas K | CEO, Pres, Dir | A - Grant | $1.16 | +21.6K | 300.8K | +8% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-13 | A | A | 21,552 | $1.16 | 300,789 | D | — | — | (F1) Form amended to include reporting person is a director and officer. |